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Pancreatic cancer has a poor prognosis attributed in part to immune suppression and
deactivation of natural killer (NK) cells. Curcuminoids have a potential for improving the
therapy of pancreatic cancer given promising results in cancer models and a clinical trial,
but their oral absorption is limited. Our objective in this study is to show curcuminoid
anti-oncogenic effects alone and together with human NK cells. We tested curcuminoids
in an emulsion of ω-3 fatty acids and anti-oxidants (“Smartfish”) regarding their direct
cytocidal effect and enhancement of the cytocidal activity of NK cells in pancreatic
ductal adenocarcinoma (PDAC) cells (Mia Paca 2 and L3.6). Curcuminoids (at ≥10µM)
with ω-3 fatty acids and anti-oxidants or with the lipidic mediator resolvin D1 (RvD1)
(26 nM) induced high caspase-3 activity in PDAC cells. Importantly, curcuminoids with
ω-3 fatty acids and anti-oxidants or with RvD1 significantly potentiated NK cell cytocidal
function and protected them against degradation. In a co-culture of cancer cells with
NK cells, interferon-γ (IFN-γ) production by NK cells was not altered by ω-3 fatty acids
with anti-oxidants or by RvD1 but was inhibited by curcuminoids. The inhibition was not
eliminated by ω-3 fatty acids or RvD1 but was relieved by removing curcuminoids after
adding NK cells. In conclusion, curcuminoids with ω-3 fatty acids and anti-oxidants or
with RvD1 have increased cytotoxic activity on PDAC cells alone and with NK cells. The
effects of curcuminoids with ω-3 fatty acids and anti-oxidants on pancreatic cancer will
be investigated in a mouse model with humanized immune system.
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Introduction
Pancreatic ductal adenocarcinoma (PDAC) is the 4th leading cause of cancer-related deaths in the
United States with an overall survival of less than 1 year and based on current statistics is predicted
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to become the 2nd leading cause of cancer-related deaths by
2020 (American Cancer Society, 2012). Chemotherapy has been
less successful in PDAC in comparison to other cancers. The
first line drug gemcitabine increased overall 1-year survival to
18% for gemcitabine-treated patients in comparison to 2% for
5-fluorouracil-treated patients (Burris et al., 1997).
The inflammatory milieu in pancreas may precede cancer
onset due to chronic pancreatitis and be intimately involved
with cancer progression. Although initially the immune cells
tend to eliminate cancer cells, they ultimately fail and actually
promote oncogenesis through IL-6 (Sideras et al., 2013). The
immune system is modulated by cancer to inhibit the cytotoxic
function of natural killer (NK) cells and CD8 T cells through
activation of regulatory T cells, myeloid derived suppressor
(MDSC) cells, tumor associated macrophages and fibroblasts.
Indeed, the cytotoxicity of NK cells from tumors and peripheral
blood of cancer patients is significantly reduced (Lai et al., 1996;
Jewett et al., 2013). The immune therapies of pancreatic cancer
using vaccination with cancer proteins and inactivated allogeneic
cancer cells and adoptive cell therapy using cytotoxic T cells have
not produced clear results in short-term trials (Sideras et al.,
2013). Thus, new approaches to pancreatic cancer treatment are
urgent.
Curcuminoids are under intensive study against cancer as they
inhibit cell proliferation through suppression of NFκB and of a
NFκB-dependent protein Akt, and suppress anti-apoptotic genes
(Aggarwal et al., 2006). By activation of various transcription
factors, curcuminoids target manifold proteins in vivo (Goel
et al., 2008). In a rat model, curcuminoids attenuated the severity
of pancreatitis (Gukovsky et al., 2003). Curcuminoids produced
FIGURE 1 | Caspase-3 induction in MP2 cells is potentiated by
curcuminoids with ω-3 and anti-oxidants. Replicate MP2 cell
cultures (N = 3) in 24-well plates were treated 24 h with curcuminoids in
Smartfish emulsion or fish oil, the cells were harvested and caspase-3
was assayed in the whole lysate. The experiment was repeated twice
with comparable results. The maximal induction of caspase-3 reached
by 10µM curcuminoids in Smartfish was greater than any other
treatment (P < 0.0001).
promising results in pancreatic cancer patients in combination
with gemcitabine (Kanai et al., 2011). However, the plasma
concentrations of curcuminoids achieved in that study were very
low (<0.5µg/ml). Thus, proper formulation of curcuminoids
for increased absorption, stability and cellular activity is needed
for clinical applications. In addition, curcuminoids block the
production of the cytokine interferon-γ that has a key role
in anti-oncogenic differentiation of cancer cells. Interferon-γ
is a member of the type II interferon family with its own
receptor, which signals through STAT-1 to transactivate IFN
response factor 1 (IRF1) and downstream secondary response
genes. (Pestka et al., 2004). Biological activities involve anti-
proliferative, anti-angiogenic, and proapoptotic effects against
cancer cells (Chawla-Sarkar et al., 2003). However, IFN-γ has
also negative pro-tumorigenic effect in cancer (Maio et al.,
1991; Zaidi and Merlino, 2011). Docosahexaenoic acid (DHA)
and eicosapentaenoic acid (EPA) are ω-3 fatty acids with anti-
cancer properties through production of toxic intermediates
(Gleissman et al., 2010) and specialized proresolving mediators
(SPMs) called resolvins, such as resolvin D1 (RvD1). Resolvins
are lipidic mediators which resolve acute inflammation and may
prevent chronic inflammation leading to cancer (Greene et al.,
2011). The Western diet lacks DHA and EPA for production of
SPMs. The low ratio of ω-3/ω-6 fatty acids in the Western diet
promotes macrophage recruitment and activation of tumorigenic
pathways. As changing the diet is difficult for many people,
supplementation with ω-3 fatty acids may optimally increase the
ω-3/ω-6 ratio in the diet.
Both curcumin and lipidicmediators fromω-3 block signaling
by NFκB but their anti-oncogenic effects have not been
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compared. Here we have examined whether the combination of
curcuminoids withω-3 fatty acids and anti-oxidants will increase
cytotoxicity directly and/or synergistically with NK cells.
Materials and Methods
Cell Culture
Pancreatic Cancer
Pancreatic cancer cells called Mia Paca2 (MP2) and L3.6 PDAC
cells were propagated in DMEM with 10% fetal calf serum and
antibiotics.
Human Subjects
The human investigations were performed after approval by the
UCLA institutional review board #11-000005 and in accordance
with an assurance filed with and approved by the U.S.
Department of Health and Human Services. Thirty healthy
donors and a patient with disseminated prostate cancer were
recruited into the study after signing an informed Consent.
NK cells
NK cells were isolated from the blood of 30 healthy subjects
by negative selection using the NK cell isolation kit (Stem
FIGURE 2 | Active caspase-3 expression in MP2 cancer cells is
potentiated by curcuminoids and ω-3 or Resolvin D1. The
MP2 cells were stained by phalloidin (green) and by rabbit antibody
to active caspase-3/anti-rabbit ALEXA568 (red). (A) Untreated MP2
cells; (B) MP2 cells treated by ω-3 with anti-oxidants (Smartfish);
(C) MP2 cells treated by curcuminoids with ω-3 and anti-oxidants
(Smartfish); (D) MP2 cells treated by RvD1 and ω-3 with
anti-oxidants(Smartfish); (E) MP2 cells treated by fish-oil; (F) MP-2
cells treated by curcuminoids in fish oil. Note the highest
expression of caspase-3 in (C,D).
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cell technologies, Vancouver, Canada). NK cells were activated
by treatment with IL-2 [termed NK(IL-2)] or IL-2 and CD16
antibody [termed NK(IL2CD16)] (BioLegend, San Diego, CA)
as described (Tseng et al., 2010). NK (IL-2) cells are activated
for cytotoxicity. NK (IL-2CD16) have decreased cytotoxicity but
increased cytokine production (“split anergy”).
Lipidic Emulsions
SmartfishR (Smartfish Company, Oslo, Norway), a lipidic
emulsion with DHA (1 gm/200ml) and EPA (1 gm/200ml)
(from local cod and salmon) protected against oxidation by
botanical anti-oxidants (polyphenols, pectin and whey proteins,
tocopherols and rosemary extract, pomegranate, chookberry)
and extremely low in environmental toxins; Smartfish/CURR
containing a supplement of curcuminoids (760mg /200ml);
control fish-oil emulsion (from imported sardines and anchovies
not protected against oxidation). For use in cell culture, each
emulsion was diluted 1:2 with fetal calf serum, sonicated for
30 s and then diluted 1:100 in DMEM with 10% fetal calf
serum. For nutritional supplementation, the prostate cancer
patient was taking one carton of the drink Smartfish/CURR
daily.
FIGURE 3 | Curcuminoids or RvD1 potentiate caspase-3
induction in MP2 cells by NK cells. (A) Caspase -3 induction in
MP2 cells: Quadruplicate MP2 cell cultures in 24-well plates were
co cultured 24 h with NK cells (5 NK cells/1 cancer cell) with ω-3
emulsion and anti-oxidants and with or without curcuminoids or
RvD1. (A–F) No caspase-3 induction by NK cells alone or
curcuminoids alone; (G,H) low induction by NK cells with ω-3 or
RvD1 (26 nM) (P = 0.016); (I–K) maximum induction by NK cells with
ω-3or RvD1 (P = 0.02). (B) Comparison of caspase-3 induction by
curcuminoids and smartfish with or without NK cells.
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Nutritional Substances
Curcuminoids (prepared from Curcuma longa L root by
extraction with acetone as granulated powder by Naturex,
Avignone, France) were prepared by sonication as an emulsion
in SmartfishR by the Smartfish company. Resolvin D1 (RvD1)
(Cayman Chemical company, Ann Arbor, MI) was emulsified in
SmartfishR.
Direct Cancer Cell Cytocidal Assay by
Curcuminoids and ω-3
MP2 cells (10,000 cells) were plated in each well of a 24-well plate
and were grown at 37 C 24 h before testing. Triplicate MP2 cell
cultures were treated for 24 or 48 h with curcuminoids, RvD1, or
other additives, harvested into the lysis buffer and tested by the
enzymatic caspase-3 assay.
Combined Cancer Cell Cytocidal Assay by NK
Cells together with Curcuminoids and ω-3
MP2 cell cultures were prepared as above. NK cells were added
to MP2 cells at a ratio of 5 NK cell per 1 MP2 cancer cell. The
co cultures were treated with various additives for 24 or 48 h and
processed as in the direct assay.
Enzymatic Caspase-3 Assay
Enzymatic caspase-3 assay was performed by the CaspACE-3
assay G-7351 (Promega Corporation, Madison, WI) according to
the manufacturer’s instructions.
Caspase-3 Immunofluorescent Assay
MP2 cells were grown to partial confluence in 8-well chamber
slides (Corning) in DMEM with 10% fetal calf serum and
were treated 24 h as stated. Then they were fixed by 4%
paraformaldehyde, permeabilized using 0.25 Triton, stained
using the indirect technique with rabbit anti-caspase-3 (active)
(Genetex, Irvine, CA) at 1:200 dilutions followed by ALEXA-
fluor-donkey anti-rabbit 568 (InVitrogen, Carlsbad, CA) at
1:200 dilutions and FITC-phalloidin (Sigma, St. Louis, M0)
at 1:500 dilution, mounted using Prolong Gold antifade with
DAPI (In Vitrogen, Carlsbad, CA). The slides were examined
using Olympus B-max fluorescence microscope at 20× and 40×
FIGURE 4 | Induction of active caspase-3 in L3.6 cancer cells by NK
cells and potentiation by ω-3 and anti-oxidants. (A) NK(IL-2) cells alone;
(B) NK(IL-2) cells and L3.6 cells; (C) NK (IL-2/CD16) cells and L3.6 cells, (D)
NK cells with ω-3 and anti-oxidants, (E) NK(IL-2) cells and L3.6 cells with ω-3
and anti-oxidants; (F) NK(IL-16) and L3.6 cells with ω-3 and anti-oxidants.
Phalloidin (green) and caspase-3 (red). NK cells are small green cells; cancer
cells are large green cells. Caspase-3 is yellow or red. Red pixels were
scanned by Image-Pro.
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magnification with theHamamatsu camera, and fluorescence was
determined in four fields using Image Pro software and expressed
as Integrated Optical Density (IOD) per macrophage.
Interferon-γ Assay
Supernatants were tested by interferon-γ ELISA assay
(BioLegend, San Diego, CA).
Statistical Analysis
Means were compared using analysis of variancemethods.Means
and their approximate 95% confidence bounds (mean ± 2
standard errors of the mean) are reported. Computations were
carried out using JMP software (SAS Inc, Cary, NC).
Results
Curcuminoids or RvD1 Have Increased Cytocidal
Activity against Pancreatic Cancer Cells When
Emulsified in ω-3 with Anti-oxidants
We tested apoptosis induction using the enzyme assay for the
executioner caspase-3 expression. In MP2 cells alone, caspase-3
expression was low (1.2µM) and was not significantly increased
by curcuminoids (1µM) alone or with ω-3 and anti-oxidants, or
by fish oil; methanol is used as a control However, curcuminoids
(10µM) emulsified in ω-3 and anti-oxidants induced robust
capase-3 expression, which was significantly higher (P < 0.0001)
than that induced by curcuminoids (10µM) in fish oil (Figure 1).
We examined apoptosis by immunofluorescence microscopy
of caspase-3 antibody stained cells (Figure 2). As shown in
integrated optical density (IOD) of red per cell, caspase-3
expression was not observed in untreated MP2 cells (IOD
Red/Cell= 21.29), but was seen at a low level in MP2 cells treated
withω-3 and anti-oxidants (IODRed/Cell= 49.87), and at a high
level in MP-2 cells treated with curcuminoids or RvD1 emulsified
in ω-3 with anti-oxidants (IOD Red/Cell = 257.01 and 227.55,
respectively). The cancer cells treated by ω-3 and anti-oxidants
became rounded, detached and some displayed pyknotic nuclei
confirming their apoptosis. The emulsification of curcuminoids
in fish oil was clearly inferior in the production of apoptosis (IOD
Red/Cell = 159.74). Comparable results were obtained in three
experiments.
Curcuminoids with NK Cells Are More Cytocidal
in Cancer Cells than Curcuminoids or NK Cells
Alone
In MP2 cells alone, MP2cells with NK (IL-2) cells, and MP2 cells
with curcuminoids (0.1–10µM), caspase-3 expression was low
(means 2.0–3.1µM) (cf. A through F in Figure 3A). Caspase-
3 expression was higher in the co culture of MP2 cells with
NK (IL-2) cells in ω-3 and anti-oxidants or with RvD1 (means
6.0–6.6µM) (cf. G and H in Figure 3A) and in a co culture of
MP2 cells with NK (IL-2) cells and curcuminoids. However, the
cytocidal activity of NK(IL-2) cells was significantly increased by
curcuminoids (P = 0.02) in ω-3 and anti-oxidants (mean =
9.8µM), in ω-3, anti-oxidants, and RvD1 (mean= 9.0µM) or in
ω-3 and RvD1 (mean = 9.5µM) (cf. I through K in Figure 3A).
Comparable results were obtained in four experiments with NK
cells, curcuminoids, ω-3 and anti-oxidants.
A comparative study of cytotoxicity by curcuminoids
alone (in ω-3 and anti-oxidants) vs. curcuminoids (in
FIGURE 5 | Interferon-γ production by NK cells is not changed by ω-3 or RvD1 but is blocked by curcuminoids. Triplicate MP2 cell cultures in 24-well plates
were cultured with NK cells with or without Smartfish emulsion, curcumin, or RvD. Note blockade of IFN-γ by curcumin.
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ω-3 and anti-oxidants) and NK cells demonstrated that
curcuminoid-enhanced NK cell cytotoxicity was greater than
direct curcuminoid cytotoxicity (Figure 3B). The experiment
was repeated three times with comparable results.
ω-3 Fatty Acids with Anti-oxidants Protect NK
Cells and increase Apoptosis of Cancer Cells
We examined caspase-3 induction by immunofluorescence
microscopy. Small NK cells are distinguished by
immunofluorescence microscopy from large L3.6 cancer
cells. Both cells are stained green in the cytoplasm and blue
in the nuclei. In this experiment (Figure 4), NK cells were
incubated overnight in DMEM with ω-3 and anti-oxidants
(Smartfish) either alone or with cancer cells. NK cells alone
remained intact when incubated in DMEM with ω-3 and
anti-oxidants in comparison to NK cells incubated in DMEM
(cf. A–D and B–E in Figure 4). In a co culture of NK(IL-2)
or NK(IL-2CD16) cells with L3.6 pancreatic cancer, cancer
cells showed increased caspase-3 expression. Active caspase-3
was shown by increased red or yellow color in the cytoplasm
of cancer cells stained with caspase-3 antibody (cf. B–E and
C–F in Figure 4) when incubated in the presence of ω-3 and
FIGURE 6 | Curcuminoid blockade of interferon-γ production is
reduced by removal of curcumin (A) after 2 days, (B) after 6 days.
Triplicate MP2 cell cultures in 24-well plates were cultured with or without
Smartfish emulsion and curcuminoids or with DMEM, washed and replaced
with the indicated medium and NK cells for 24 or 48 h. Note that the
inhibition of IFN-γ by curcuminoids was reduced by washing MP2 cells.
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anti-oxidants in comparison to medium as shown in integrated
optical density (IOD) of red per cell. In case of NK(IL-2), IOD
increased from 749.23 to 3644.60 in the presence of ω-3 and
anti-oxidants, and in case of NK(IL-2/CD16), IOD increased
from 764.10 to 10763.42 in the presence of ω-3 and anti-oxidants
(Figure 4).
Curcuminoids Inhibit the Production of
Interferon-γ by NK Cells during Co-incubation
with MP2 Cancer Cells
No IFN-γ was produced by NK (IL-2) cells alone. High level
of IFN-γ was produced by NK(IL-2) cells in a co culture with
cancer cells with or without ω-3 and anti-oxidants or RvD1.
Curcuminoids (10µM) with or without ω-3 and anti-oxidants
or RvD1 completely blocked production of IFN-γ (Figure 5).
We tested the effect on IFN-γ production of incubation of
the cells in a curcuminoid-free medium after addition of NK
cells. The curcuminoid-free interval after addition of NK cells
resulted in the following mean IFN-γ levels: (a) co culture of
NK and cancer cells without curcuminoids for 48 h: 201 pg/ml;
(b) co culture without curcuminoids for 24 h: 90 pg/ml; (c)
co culture with constant presence of curcuminoids for 48 h:
27 pg/ml (Figure 6A). When the experiment was increased to
96 h, the reduction in inhibition was still observed (Figure 6B).
Discussion
We evaluated the induction of the apoptosis executioner caspase-
3 by curcuminoids and ω-3 or the lipid mediator RvD1 in PDAC
cells as (a) direct effects, and (b) combined effects with NK
cells. The analysis of direct effects showed that curcuminoids
alone were poorly effective but had strong cytotoxic effects in
dose-related fashion when administered in an emulsion of ω-
3 with anti-oxidants in comparison to an emulsion in fish oil.
The cytotoxic activity of NK cells was enhanced by ω-3 and
anti-oxidants and was maximally enhanced by curcuminoids
and ω-3 fatty acids with anti-oxidants. Thus, NK cells either
with curcuminoids, ω-3 fatty acids and anti-oxidants or RvD1
(at 1000 lower concentration) induced maximal caspase-3. We
also evaluated cytotoxicity by immunofluorescence microscopy
in MP2 and L3.6 cancer cells. The results confirmed the increase
of cidal effects from the culture in ω-3 and anti-oxidants to the
culture in ω-3, anti-oxidants and curcuminoids (Figure 2) and
from the culture with NK(IL-2) cells to NK(IL-2)cells, ω-3, anti-
oxidants (Figure 4). Caspase-3 was activated in both cancer cells
and NK cells, but the activation was much increased by ω-3
and anti-oxidants or RvD1 (Figure 3A). In addition, NK cells
were protected against degradation after overnight incubation in
DMEM with ω-3 and anti-oxidants in comparison to DMEM
(Figure 4). Although previous studies showed potentiation of
cytotoxic effects of NK cells against cancer cells by curcuminoids
(Zhang et al., 2007), in our study these effects were further
enhanced by the synergy between curcuminoids and ω-3 or
RvD1. A previous study demonstrated an increase by curcumin
of the caspase-8, which is upstream of caspase-3 in the execution-
phase of apoptosis (Kim et al., 2005).
Curcuminoids inhibited the production of IFN-γ by NK cells
in our study of pancreatic cancer cells and in a study of human
melanoma cells (Bill et al., 2009). The latter group prepared a
curcumin analog FLLL32 which does not block IFN-γ production
by NK cells (Bill et al., 2010). The effect of curcuminoids on IFN-
γ was reduced when curcuminoid treatment was reduced in time
after the addition of NK cells (Figure 6).
In conclusion, our cell culture study showed dissociation
between enhancing effects of curcuminoids on apoptosis and
inhibiting effects on IFN-γ production byNK cells. In application
to cancer therapy, it will be important to determine whether the
inhibitory effect of curcuminoids on IFN-γ production could be
modified by intermittent therapy. In the future work, we plan
to study the cytocidal effects of curcuminoids, ω-3, and anti-
oxidants in vivo in an animal model and ultimately in human
patients. We are preparing such study in a model of pancreatic
cancer with humanized immune system.
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